Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures

Publisher DOI
PubMed ID
19841590
Description
Raltegravir (RAL) achieved remarkable virologic suppression rates in randomized-clinical trials, but today efficacy data and factors for treatment failures in a routine clinical care setting are limited.
Date of Publication
2010
Publication Type
Article
Language(s)
en
Contributor(s)
Scherrer, Alexandra U
von Wyl, Viktor
Opravil, Milos
Bucher, Heiner C
Fayet, Aurélie
Decosterd, Laurent A
Hirschel, Bernhard
Khanlari, Bettina
Yerly, Sabine
Klimkait, Thomas
Ledergerber, Bruno
Günthard, Huldrych F
Swiss HIV Cohort Study
Additional Credits
Series
Journal of acquired immune deficiency syndromes JAIDS
Publisher
Lippincott Williams & Wilkins
ISSN
0894-9255
Access(Rights)
metadata.only
Show full item